VANCOUVER, British Columbia–(CRWENEWSWIRE)– ProtoKinetix (OTCBB:PKTX.OB) (www.protokinetix.com), a biotechnology company that has developed and patented a family of synthetic anti-aging glycopeptides (AAGP™) for medicine, biotechnology and cosmetic industries recenty issued Question and Answer sessions with Ross L. Senior, CEO of ProtoKinetix regarding the effective uses of the AAGP™ molecule.

Details of the Q and A:

Q: What does ProtoKinetix management believe that is so unique about their AAGP™ molecule?

A: This small, stable molecule is a platform for numerous commercial applications. It has repeatedly demonstrated anti-inflammation properties that can treat a whole array of auto-immune diseases including Type 1 Diabetes, Rheumatoid Arthritis, Lupus, etc. Containment control or preservation of inflammation is probably the most important health care goal. Current treatments for inflammation are extremely limited and can cause severe side-effects.

Q: How can ProtoKinetix make such a wide sweeping claim?

A: The damage that is done by auto-immune attacks is caused by inflammation. Inflammation causes cell death, which in turn leads to tissue destruction and ultimately organ failure. AAGP™ has demonstrated that it prevents inflammation at the point of origin. Our studies have shown AAGP™ to protect cells from inflammatory stresses.

Q: What does the trade mark AAGP™ stand for?

A: It stands for anti-aging glycopeptides. By virtue of AAGP™ anti-inflammatory qualities, the molecule enhances the health and extends the life of cells, even under highly stressful conditions.

Q: What are highly stressful conditions?

A: Highly stressful conditions are events that initiate an inflammation response from a cell. These events could be toxins, antibodies, pathogens and other forms of hostility.

The Company has tested, and have also independently tested, a wide variety of hostile agents against a large number of different cells types. ProtoKinetix is now in a position to commence testing against specific diseases such as Type 1 Diabetes, Iritis, Dermatitis, Rheumatoid Arthritis, etc. Some of the stressful conditions that ProtoKinetix has tested against are:

All bands of ultra violet radiation
Oxidative stresses
Starvation
Cryopreservation
Inflammation caused by the direct application of Interleukin 1 Beta

All test provided consistent protective results.

Q: When will testing start on specific diseases?

A: Right now. The Company has laid the ground work by covering the basics. ProtoKinetix is presently in dialogue with laboratories that have the capacity, expertise and credibility to build a convincing array of data that will result in drug development based on this molecule. In addition, we have partnered with a company that is highly respected in the field of formulating topical applications for skin conditions. Using AAGP™ as an active anti-inflammatory ingredient, we will be targeting dermatitis and psoriasis.

Q: It sounds like ProtoKinetix is a long way away from any meaningful revenue. Is this the case?

A: No. The Company’s revenue starts with the signing of a licensing development deal- although the drug for the treatment of Type 1 Diabetes may be several years away, the license fees and royalties will start immediately.

Q: Why has recognition of AAGP™ taken so long?

A: It took considerable time to demonstrate the extremely wide range of therapeutic applications. Also, until recently, science and medicine have been focused on the cure as opposed to the effects of the disease, namely inflammation. The health industry today has come to uniformly accept that the priority lies in the successful suppression of inflammation.

Since these recent interviews took place, two major initiatives have commenced. ProtoKinetix has entered into a Joint Venture to produce a non-steroidal topical skin application and has laid the foundation of a research development program for inflammation of the eye.

About ProtoKinetix

ProtoKinetix, Inc. is a biotechnology company that has developed and patented a family of synthetic anti-aging glycopeptides (AAGP™) for medicine and the biotechnology and cosmetic industries. PKTX’s primary focus is on the therapeutic potential for AAGP™ in the treatment of Diabetes, inflammatory diseases, skin protection and anti-aging.

The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” for forward-looking statements. Some information included in this press release contains statements that are forward-looking. Such forward-looking information involves significant risks and uncertainties that could affect anticipated results in the future and, accordingly, these results may differ materially from those expressed in any forward-looking statements made by or on behalf of the Company. For a description of additional risks and uncertainties, please refer to the Company’s filings with the Securities and Exchange Commission.

Source: ProtoKinetix Inc.

Ross L. Senior – President and CEO

Contact:

ProtoKinetix Inc.
Blair Henderson, 604-926-6627

********************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWENewswire.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWENewswire.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwenewswire.com/disclaimer). Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

Capital City Bank Group, Inc. (Nasdaq:CCBG) will address analysts and investors attending the 2011 Gulf South Bank Conference on May 10, 2011.

CCBG is scheduled to present at 8:45 a.m. ET. J. Kimbrough Davis, executive vice president and chief financial officer, and Dale A. Thompson, executive vice president and chief credit officer, will discuss CCBG strategy, recent business developments and market opportunities.

*************************

Power3 Medical Products, Inc. (PWRM.OB)

Power3 Medical Products, Inc., a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, recently announced PWRM management believes it is making great progress in its focus on the development, sales, and marketing of its proprietary innovate diagnostic tests for breast cancer, pancreatic cancer, ovarian cancer, colon cancer, and certain neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, to name a few.

In addition, PWRM is a party to several litigation matters, most of which relate to various toxic debt instruments that were entered into by PWRM several years ago when it operated under the tenure of Chairman and CEO, Steven B. Rash. Because current management believes these toxic debt instruments are responsible for PWRM’s depressed stock price and have distracted the company from its mission, PWRM plans to settle as many of these nagging lawsuits as possible prior to the completion of its merger with Rozetta-Cell Life Sciences, Inc. As for those lawsuits that cannot be speedily resolved, PWRM will continue to rigorously defend its position. For example, one such lawsuit involves Neogenomics, Inc., which was recently granted a motion for summary judgment with respect to an amount due under a convertible debenture. PWRM intends to appeal this decision.

“We are very excited to be finally ridding ourselves of litigation that has plagued us for several years now,” stated Ira L. Goldknopf, President and Chief Scientific Officer of PWRM. “We have big plans for the future beginning with our upcoming acquisition of Rozetta-Cell and are about to enter a long and substantial growth phase marked by advances in our science and intellectual property. Given the imminent nature of many of these transactions and breakthroughs, we have decided, in consultation with the financiers of Rozetta-Cell, that the best course of action for Power3 is to settle many of these lawsuits so that we can focus our attention exclusively on the acquisition of Rozetta-Cell and the development of our combined businesses after the merger.”

Rozetta-Cell Life Sciences, Inc. is a medical biotechnology company that focuses on the delivery and imaging of stem cells during therapy. PWRM plans to effect the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into PWRM, with PWRM remaining as the surviving company. The acquisition of Rozetta-Cell is expected to be completed in 2011.

Power3 Medical Products, Inc., a bio-technology company, engages in the development and marketing of diagnostic tests in the fields of cancer, and neurodegenerative and neuromuscular diseases in the United States. The company was formerly known as Surgical Safety Products, Inc. and changed its name to Power3 Medical Products, Inc. in September 2003. Power3 Medical Products, Inc . was founded in 1992 and is based in The Woodlands, Texas.

To discover more about PWRM visit: http://www.Power3Medical.com

*************************

HCC Insurance Holdings, Inc. (NYSE:HCC) recently reported that HCC Chief Executive Officer John N. Molbeck, Jr. and President Christopher J.B. Williams will be presenting at the Tenth Annual JMP Securities Research Conference in San Francisco, California on Tuesday, May 10, 2011, beginning at 9:00 a.m. Pacific Daylight Time.

*************************

Orofino Gold Corp. (ORFG.PK)

Orofino Gold Corp. (OTCQB: ORFG) has been working with Colombian utilities supplier Electricaribe to establish power to the villages of the local populations within Orofino’s concessions. Buena Sena was supplied with electricity in July of 2010. And by mid May, Orofino expects to have complete electrical service established at La Azul.

La Azul’s connection is coming from an intermediate station operating at 13,200 cycles/second located in the town of Rio Viejo. Once operational, La Azul’s infrastructure is expected to initially be tied into a 50 kva transformer.

“When the power connection was established in Buena Sena last year, it was a very important date for that community,” explains Orofino President and CEO, Mr. Ary F. Pernett Marquez. “Imagine what it would be like to have publicly supplied electricity for the first time in your life. We’re excited that the residents and miners of La Azul will also be getting the benefits of such a vital piece of infrastructure.”

In addition to providing a critical piece of infrastructure to promote growth of La Azul village, Orofino expects the connection to the region’s power grid to significantly improve production capabilities of mine workers. As current production is being performed with outdated equipment powered only by generators, connecting La Azul to the region’s power grid will enable Orofino to introduce modern mining equipment and technology.

One of the most significant and noteworthy industrial use of gold is in the manufacture of electronics. Solid state electronic devices do not use a great amount of voltage and currents and which can be interrupted due to corrosion or tarnish at the contact points. Gold nonetheless is the very efficient conductor that is able to take the small currents and that will not become corroded. The electronic components that are made with gold are also very dependable. Gold is used in a lot of electronic components such as in connectors, switch and relay contacts, soldered joints, connection strips, connecting wires etc. almost all of the modern electronic devices we have these days have a little amount of gold in them. Some of the devices that one utilizes every day have gold in them such as in the case of cell phones, personal digital assistants, calculators and many other little electronic devices and obviously the bigger electronic appliances also have gold in them such as in the case of televisions etc.

ORFG’s Mission

To become a 100,000 ounce gold producer from first mine and to replicate this on each of the current optioned properties.

The vision of Orofino Gold Corp.:

* To become a good Joint Venture Partner

* To become a premier Mid Tier precious metals mining operation in Colombia

* To fast track first mine to commercial production.

For more information about Orofino Gold Corp., please visit their website: http://www.orofinogold.com

*************************

BPZ Resources, Inc., d/b/a BPZ Energy (NYSE:BPZ), an independent exploration and production company, recently reported that it has scheduled a conference call and webcast to discuss first quarter 2011 results on Tuesday, May 17, 2011, at 10:00 a.m. CDT (11:00 a.m. EDT).

***********************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB). Crown Equity Holdings Inc. (CRWE.OB) has previously received 500,000 shares of (144) restricted common stock and 500,000 shares of free trading shares from a third party (QU CUI You) for six months of advertisement services (which has expired) for Orofino Gold Corp. (PINK SHEETS:ORFG).

********************

AT&T, Inc. (NYSE:T) announced its AT&T Office@Hand app for iPhone, a mobile PBX application which allows small businesses with an existing wireless account from AT&T to configure and manage their office phone system on-the-go. The app, available now on the App Store, represents the latest example of AT&T’s commitment to help small businesses wirelessly enable their operations and expands the company’s portfolio of fixed mobile communication capabilities.

AT&T Inc. provides telecommunication products and services to consumers, businesses, and other telecommunication service providers under the AT&T brand worldwide. The company’s Wireless segment offers wireless voice communications services, including local wireless communications, long-distance, and roaming services with various postpaid and prepaid service plans.

********************

Spectra Energy Corp. (NYSE:SE) Chief Financial Officer, Pat Reddy, will speak at the Credit Suisse Energy Summit on Tuesday, February 8, 2011, in Vail, Colo. The presentation is scheduled to begin at approximately 11:10 a.m. MT (1:10 p.m. ET) and will be available via audio webcast. The presentation and webcast link can be accessed via the Investors Section of Spectra Energy’s Web site at www.spectraenergy.com. A replay of the webcast will be available for up to three months following the event.

Spectra Energy Corp, through its subsidiaries and equity affiliates, engages in the ownership and operation of a portfolio of complementary natural gas-related energy assets.

********************

Orofino Gold Corp. (ORFG.PK) has projects such as La Azul, San Carlos and Culo Alzado. La Azul is one producing artesanal mine in the Senderos de Oro area controlled by Orofino, it is a mixed sequence of predominantly volcanic rocks with the vein systems comprised of high grade chalcopyrite, galena and sphalerite with pyrite in quartz veins.

Gold is found in ores made up of rock with very small or microscopic particles of gold. This gold ore is often found together with quartz or sulfide minerals such as Fool’s Gold, which is a pyrite. These are called lode deposits. Native gold is also found in the form of free flakes, grains or larger nuggets that have been eroded from rocks and end up in alluvial deposits (called placer deposits). Such free gold is always richer at the surface of gold-bearing veins owing to the oxidation of accompanying minerals followed by weathering, and washing of the dust into streams and rivers, where it collects and can be welded by water action to form nuggets.

The Senderos de Oro Project is comprised of more than 3000 hectares of Gold and other mineral concessions in the minera mining area of central Sur de Bolivar. The Project resembles the La Bodega and Vetas California Projects, currently being explored and developed by Canadian Exploration Company Ventana Gold, for which EBX recently extended an unsolicited tender offer of $1.3 Billion.

La Azul is one producing artesanal mine in the Senderos de Oro area controlled by Orofino, it is a mixed sequence of predominantly volcanic rocks with the vein systems comprised of high grade chalcopyrite, galena and sphalerite with pyrite in quartz veins.

It has been interpreted (by Shaw 1993) that the metallogenic zonation around the La Azul workings evokes a very viable “hidden porphyry” exploration model. This interpretation and the prospectivity of the area have been confirmed by the Orofino “qualified person” as per the 43-101 rules.

Orofino will move ahead aggressively to pursue the current interpretations, work programs and drilling will begin soon.

Orofino Gold is a China based Gold and Silver Exploration Company founded as a private company in 2009 by former executives with over 50 cumulative years in mining exploration, finance, and development expertise. Orofino’s corporate objective is to continue to build shareholder value through the exploration and development of Senderos de Oro and additional accretive acquisitions, capitalizing on the extensive experience and relationships that management has developed over the past 25 years.

********************

Power3 Medical Products, Inc. (OTC.BB:PWRM), has filed several patent applications for its NuroPro technology that are currently pending. Power3 also has a world-wide exclusive license from the Baylor College of Medicine in Houston, Texas. To date, Power3 has given 9 presentations on NuroPro at international scientific meetings in the United States, Europe and China, and has published 6 articles in peer-reviewed scientific journals on the subject. Power3 intends to publish these latest findings as well.

“We are within striking distance of realizing an Alzheimer’s clinical diagnostic tool which I hope will lead to a greater understanding of the disease and buoy the pace of future therapeutic interventions,” added Marwan Sabbagh MD, Medical and Scientific Director of Banner Sun Health Medical Research Institute.

Alzheimer’s illness (AD)-also called Alzheimer disease, senile dementia of the Alzheimer type (SDAT), primary degenerative dementia of an Alzheimer’s type (PDDAT), or Alzheimer’s-is the most common sort of dementia. This unique incurable, degenerative, and deadly disorder was first explained German born professional as well as neuropathologist Alois Alzheimer in 1906 and was called after him. Most often, it really is determined in individuals over 65 years of age, although the less-prevalent early-onset Alzheimer’s can take place much earlier. In 2006, there have been 26.6 million patients globally. Alzheimer’s is predicted to threaten 1 in 85 people today worldwide by the year 2050

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease).

For more information about this company please visit http://www.power3medical.com

********************

American Water Works Company, Inc. (NYSE:AWK) announced that it will host an Investor Conference on Tuesday, February 15 at the New York Stock Exchange. A live webcast of the conference will be accessible to the public from 8:00 a.m. to approximately 11:30 a.m. Eastern time, and posted on the investor relations section of the company’s website at www.amwater.com. The company will also issue a press release the morning of February 15 relaying preliminary fourth quarter and year-end 2010 results, as well as 2011 earnings guidance.

American Water Works Company, Inc. provides water and wastewater services to residential, commercial, and industrial customers in the United States and Canada. As of December 31, 2009, the company served approximately 16 million people with drinking water, wastewater, and other water-related services in 35 states and two Canadian provinces.

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer). Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services from Power 3 Medical Products Inc. (PWRM.OB). Crown Equity Holdings Inc. (CRWE.OB) has received 500,000 shares of 144 stock in Orofino Gold Corp. (PINK SHEETS: ORFG) valued at sixty five thousand dollars, and 500,000 shares of free trading shares valued at sixty five thousand dollars from a third party (QU CUI You) for 30 days advertising.